Emergent Biosolutions EBS Contract with Customer, Liability
Contract with Customer, Liability at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's contract with customer, liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's contract with customer, liability?
- Emergent Biosolutions (EBS) reported contract with customer, liability of $17.6M in Q1 2026.
- How has Emergent Biosolutions's contract with customer, liability changed year-over-year?
- Emergent Biosolutions's contract with customer, liability increased by 97.8% year-over-year, from $8.9M to $17.6M.
- What is the long-term trend for Emergent Biosolutions's contract with customer, liability?
- Over 5 years (2020 to 2025), Emergent Biosolutions's contract with customer, liability has grown at a -32.1% compound annual growth rate (CAGR), from $100.1M to $14.4M.